Scarica l'app Stockscreener
7.51
4.74%
0.34
Dopo l'orario di chiusura:
7.60
0.09
+1.20%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BHC Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Bausch Health Companies Inc Borsa (BHC) Ultime notizie
Bausch Health (BHC) Rebounds 15.8% on Bargain-Hunting - MSN
Paulson John buys $312 million in Bausch Health (BHC) shares - Investing.com
Resistance Break Could Fuel Bausch Health Companies Inc. RallyJuly 2025 Sentiment & Weekly High Momentum Picks - newsyoung.net
John Paulson buying at Bausch Health Companies (BHC) - The Globe and Mail
DURECT Corporation Reports Second Quarter 2025 Financial Results and Provides Update on Proposed Acquisition by Bausch Health - The Malaysian Reserve
Form PRE 14A Bausch Health Companies For: Oct 07 - StreetInsider
Durect and Bausch Health Merger on Track to Close in Q3 - AInvest
Bausch Health's Durect Acquisition: Strategic Valuation and Risk Mitigation in Biopharma M&A - AInvest
Biotech DURECT Gets $63M Buyout Offer from Bausch Health with $350M Future Payment Potential - Stock Titan
IBS in America: Despite advances, IBS remains a burden for many millions - Benzinga
Why Bausch Health Stock Surged By Nearly 20% (NYSE:BHC) - Seeking Alpha
Bausch Health reaffirms 2025 revenue target of $4.95B–$5.1B as debt reduction and pipeline expansion advance - MSN
Bausch Health Companies Inc. shares fall 1.65% premarket as TSX steadies with tech stocks rising. - AInvest
United States Epilepsy Drugs Market Trends and Company - GlobeNewswire
Is This a Bottoming Phase for Bausch Health Companies Inc.Intraday Trend Analysis for Fast Gains Released - metal.it
Bausch Health to Acquire DURECT Corporation in $63M Deal to Advance Liver Disease Treatment - MSN
Is Bausch Health Companies Inc. Forming a Consolidation BaseShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Saudi Arabia OTC Artificial Tears Market Forecast and - GlobeNewswire
Saudi Arabia OTC Artificial Tears Market Forecast and Company Analysis Report 2025-2033 Featuring AbbVie, Akorn, Alcon, Bausch Health, J&J, Nicox, Novartis, Santen Pharmaceutical, Sun Pharmaceutical - Yahoo Finance
Bausch Health Announces 2025 Gastrointestinal Health Scholars Program Winners - The Daily Corinthian
Bausch Health's $100K GI Health Scholarship Program Empowers 10 Students Despite Medical Challenges - Stock Titan
Bausch Health Companies Inc. shares fall 2.95% intraday as Toronto stocks climb to fresh highs. - AInvest
Bausch Health to Acquire DURECT Corporation, Strengthening Commitment to Developing Innovative Solutions for Patients with Liver Disease - biomb.ca
Bausch Health Companies Inc. shares rise 2.68% intraday after Viatris Inc. appoints David Simmons to its Board of Directors. - AInvest
Liver Cirrhosis Market Predicted to See Upsurge Through 2034, Highlights DelveInsight | Pfizer, GlaxoSmithKline, Bausch Health, Bristol-Myers Squibb, Mallinckrodt, Cumberland - Barchart.com
Saudi Arabia Vision Care Market Forecast and Company - GlobeNewswire
Saudi Arabia Vision Care Market Forecast and Company Analysis Report 2025-2033 Featuring Essilor, J&J, Bausch Health, Novartis, Grand Vision, Carl Zeiss, Valeant, Paragon Vision Science, Menicon - Yahoo Finance
Is Bausch Health Companies Inc. a growth stock or a value stockFree Daily Trading Room Entry - Jammu Links News
What are the technical indicators suggesting about Bausch Health Companies Inc.Fastest-growing stock picks - Jammu Links News
What are analysts’ price targets for Bausch Health Companies Inc. in the next 12 monthsBuild a diversified portfolio for stability - Jammu Links News
What institutional investors are buying Bausch Health Companies Inc. stockBuild a winning portfolio with smart picks - Jammu Links News
What analysts say about Bausch Health Companies Inc. stockInvest confidently with professional guidance - Jammu Links News
Does Bausch Health Companies Inc. stock perform well during market downturnsGet timely alerts on market opportunities - Jammu Links News
How does Bausch Health Companies Inc. compare to its industry peersConsistently superior profits - Jammu Links News
What catalysts could drive Bausch Health Companies Inc. stock higher in 2025Track high-yield stocks before they peak - Jammu Links News
Lacklustre Performance Is Driving Bausch Health Companies Inc.'s (NYSE:BHC) 25% Price Drop - 富途牛牛
How many analysts rate Bausch Health Companies Inc. as a “Buy”Discover market opportunities with real-time data - Jammu Links News
What is the dividend policy of Bausch Health Companies Inc. stockRapid capital growth - Jammu Links News
Bausch Health Companies Inc. (NYSE:BHC) Q2 2025 Earnings Call Transcript - Insider Monkey
Bausch Health Companies Inc. Attempts Reversal From Key SupportNews Based Entry Opportunity Alerts Detected - metal.it
Real Time Data Flags Unusual Activity in Bausch Health Companies Inc.Profit Target Stock Opportunity Monitor Activated - metal.it
Bausch Health to acquire liver drug developer Durect for $1.75 per share - MSN
Bausch Health Companies Second Quarter 2025 Earnings: Beats Expectations - Yahoo Finance
Bausch Health Companies Inc. Bounces Off Moving Average SupportFast Return Equity Trade Forecast Points to Small Caps - metal.it
Bausch Health to redeem ~$602M of outstanding notes due 2026 - MSN
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat - MSN
Bausch Health Delivers Ninth Straight Quarter Of Growth - Finimize
How strong is Bausch Health Companies Inc. company’s balance sheetBest Dividend Tips With High Returns - Jammu Links News
Bausch Health’s Earnings Climb, But The Road Ahead Stays Cloudy - Finimize
Bausch Health Companies Inc. SEC 10-Q Report - TradingView
Bausch: Q2 Earnings Snapshot - Connecticut Post
1.29%
1.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):